Possible involvement of an endogenous benzodiazepine receptor ligand of the inverse agonist type in the regulation of rapid-eye movement (REM) sleep: an hypothesis.
1. Rapid-eye movement (REM) sleep is a complex behavioral state characterized by desynchronized electroencephalographic (EEG) activity, postural atonia, rapid, saccadic movements of the eyes, and vivid dreaming. 2. A recently developed class of drugs, the inverse agonist beta-carboline-3-carboxylates, elicits a number of effects similar to the properties of REM sleep, such as desynchronized cortical EEG and penile erections. 3. The hypothesis is put forth that an endogenous beta-carboline-3-carboxylate exists which may initiate many aspects of REM sleep. 4. Clinical relevance of this hypothesis is discussed with regard to REM anxiety dreams, night terrors, narcolepsy, and depression.